The identification of VHL gene mutations in the tumor DNA, corresponding to the donor genotype, established that the cancer in the transplanted kidney originated from an inherent genetic predisposition of the transplant’s renal parenchyma, i.e. the donor tissue, to the development of RCC. The gene discussed is VHL; the disease is cancer.